Delphia (USA)’s MiMedx Group MDXG Stock Holding History

Delphia (USA)’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,573	Closed	-$55K	–	452
2022 Q1	$55K	Buy	+11,573	New	+$56.6K	0.04%	319

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BMO

Beck Mack & Oliver New York $4.85B AUM 9.66% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Delphia (USA)'s MDXG Position: Q2 2022 in Review

Delphia (USA) sold out of MiMedx Group (MDXG) in Q2 2022, closing a stake of 11,573 shares — an estimated $55K sold.

Delphia (USA) first reported a position in MDXG in Q1 2022 and held it in 1 quarter. The position peaked at $55K in Q1 2022. 153 funds tracked by Wall St. Rank hold MDXG as of Q2 2022.

Delphia (USA) reported no remaining MiMedx Group position as of Q2 2022 after selling out during the quarter.
Delphia (USA) sold 11,573 MiMedx Group shares in Q2 2022, an estimated $55K.
Delphia (USA) first reported a position in MiMedx Group in Q1 2022 and held it in 1 quarter.
Delphia (USA)'s MiMedx Group position peaked at $55K in Q1 2022.
153 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2022.

Based on Delphia (USA)'s 13F filing for Q2 2022, filed 15 Aug 2022.